A case of emetophobia responding to mirtazapine and propranolol treatment
dc.authorid | 0000-0002-8930-2261 | en_US |
dc.authorid | 0000-0002-8848-4956 | en_US |
dc.authorid | 0000-0002-3412-9879 | en_US |
dc.authorid | 0000-0001-5207-6240 | en_US |
dc.contributor.author | Köksal, Merve | |
dc.contributor.author | Koçak, Gökçe | |
dc.contributor.author | Öztürk, Yusuf | |
dc.contributor.author | Tufan, Ali Evren | |
dc.date.accessioned | 2023-11-22T08:29:07Z | |
dc.date.available | 2023-11-22T08:29:07Z | |
dc.date.issued | 2022 | en_US |
dc.department | BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Emetophobia (“phobia of vomiting and nausea” or “Specific Phobia- Other [Vomiting]” in Diagnostic and statistical manual of mental disorders-Fifth Edition [DSM-5]) is characterized by impairing, chronic phobic avoidance of nausea/vomiting as well as inordinate cognitive and autonomic responses when avoidance is not possible.1,2 Patients may have elevated disgust sensitivity, a tendency to display gastrointestinal symptoms of anxiety as well as misinterpretation of those symptoms as catastrophic.2 Data on pharmacological management of emetophobia among adolescents is limited with only 2 cases benefiting from selective serotonin reuptake inhibitors (fluoxetine and sertraline) while adults may also benefit from benzodiazepines. 3-5 Patients may apply to various medical specialty clinics for treatment and this may delay diagnosis and management. Here; we aim to present an adolescent with emetophobia and its management by mirtazapine and propranolol. | en_US |
dc.identifier.citation | Köksal, M., Koçak, G., Öztürk, Y., & Tufan, A. E. (2022). A Case of Emetophobia Responding to Mirtazapine and Propranolol Treatment. Journal of Neurogastroenterology and Motility, 28(4), 709-710. | en_US |
dc.identifier.doi | 10.5056/jnm22133 | |
dc.identifier.endpage | 710 | en_US |
dc.identifier.issn | 2093-0879 | |
dc.identifier.issn | 2093-0887 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 36250377 | en_US |
dc.identifier.scopus | 2-s2.0-85141550518 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 709 | en_US |
dc.identifier.uri | http://dx.doi.org/10.5056/jnm22133 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/11870 | |
dc.identifier.volume | 28 | en_US |
dc.identifier.wos | WOS:000877926500018 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Köksal, Merve | |
dc.institutionauthor | Koçak, Gökçe | |
dc.institutionauthor | Öztürk, Yusuf | |
dc.institutionauthor | Tufan, Ali Evren | |
dc.language.iso | en | en_US |
dc.publisher | Korean Society of Neurogastroenterlogy and Motility | en_US |
dc.relation.ispartof | Journal of Neurogastroenterology and Motility | en_US |
dc.relation.publicationcategory | Editöre Mektup - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Emetophobia | en_US |
dc.subject | Serotonin | en_US |
dc.subject | Propranolol Treatment | en_US |
dc.title | A case of emetophobia responding to mirtazapine and propranolol treatment | en_US |
dc.type | Letter | en_US |